Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Gastroenterology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?
7
Mins
March 2025
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…
Read more
6
Mins
18 Mar 2020
New dimensions: exploring recent data and measures in IBD
UC is a chronic, progressive disorder with an unknown aetiology.1 Few population-based cohort studies have assessed both disease course and the use…
7
Mins
17 Mar 2020
Artificial Intelligence in Colonoscopy
CRC is the third most common form of cancer globally, with 1.8 million new cases diagnosed every year…
7
Mins
12 Dec 2019
The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has become an emerging disease throughout the world. Metabolic comorbidities such as obesity…
4
Mins
5 Dec 2019
‘Old but Gold’ – Insights About Anti-TNF-α Therapy in the Treatment of Inflammatory Bowel Disease
Prof Panaccione believed that biologic therapies are generally underutilised in patients with IBD; they are started too late and prescribed to too few…
4
Mins
5 Dec 2019
Making the Invisible Visible: The Hidden Cost of Paediatric Inflammatory Bowel Disease
Europe has the leading prevalence rates of inflammatory bowel diseases (IBD) in the world. It is estimated that 2.5–3.0 million people on the continent bear the condition,1 and the associated costs are on the rise…
9
Mins
5 Dec 2019
Editor’s Pick: Refractory Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Management
Gastroesophageal reflux disease (GERD) is a common gastrointestinal (GI) disorder worldwide. Proton pump inhibitors (PPI) are the mainstay of treatment…
5
Mins
5 Dec 2019
Burning Questions in Inflammatory Bowel Disease: Learnings from Emerging Drug Options and Clinical Cases
The treatment armamentarium is expanding for patients with UC and Crohn’s disease (CD). The treatments currently available include anti-inflammatory…
8
Mins
5 Dec 2019
Who Audits Who Using Resection Margins: The Surgeon, or the Pathologist?
Colorectal cancer (CRC) is one of the most common malignancies in the developed world and with the ‘westernisation’ of diets, other parts of the world…
Loading posts...
« Previous
1
…
8
9
10
11
12
…
23
Next »